Cardlytics Stock Today

CDLX Stock  USD 3.80  0.13  3.54%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 60

 
High
 
Low
Above Average
Cardlytics is trading at 3.80 as of the 21st of November 2024; that is 3.54 percent increase since the beginning of the trading day. The stock's open price was 3.67. Cardlytics has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Cardlytics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of December 2022 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain
Media & Entertainment
IPO Date
9th of February 2018
Category
Communication Services
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. The company has 50.82 M outstanding shares of which 7.1 M shares are currently shorted by private and institutional investors with about 11.41 trading days to cover. More on Cardlytics

Moving against Cardlytics Stock

  0.65YY YY Inc Class Earnings Call This WeekPairCorr
  0.56VZ Verizon Communications Aggressive PushPairCorr
  0.55TC TuanChe ADRPairCorr
  0.53TU Telus CorpPairCorr
  0.42ZH Zhihu Inc ADR Earnings Call This WeekPairCorr

Cardlytics Stock Highlights

ESG Sustainability
Environmental
Governance
Social
PresidentJared Luskin
Business ConcentrationAdvertising, Media & Entertainment, Communication Services, NASDAQ Composite, Communication Services, Media, Advertising Agencies, Communication Services (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.870.5385
Way Up
Slightly volatile
Gross Profit Margin0.30.4217
Way Down
Slightly volatile
Total Current Liabilities135.4 M171.1 M
Significantly Down
Slightly volatile
Non Current Liabilities Total206.5 M268.2 M
Significantly Down
Pretty Stable
Total Assets440 M574.1 M
Way Down
Slightly volatile
Total Current Assets213.8 M223.9 M
Sufficiently Down
Slightly volatile
Debt Levels
Cardlytics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardlytics' financial leverage. It provides some insight into what part of Cardlytics' total assets is financed by creditors.
Liquidity
Cardlytics currently holds 266.11 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity.

Depreciation

16.84 Million
Cardlytics (CDLX) is traded on NASDAQ Exchange in USA. It is located in 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 and employs 456 people. Cardlytics is listed under Advertising category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 186.52 M. Cardlytics conducts business under Media sector and is part of Communication Services industry. The entity has 50.82 M outstanding shares of which 7.1 M shares are currently shorted by private and institutional investors with about 11.41 trading days to cover. Cardlytics currently holds about 157.04 M in cash with (185 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cardlytics Probability Of Bankruptcy
Ownership Allocation
Cardlytics holds a total of 50.82 Million outstanding shares. Over half of Cardlytics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cardlytics Ownership Details

Cardlytics Stock Institutional Holders

InstituionRecorded OnShares
Nuveen Asset Management, Llc2024-06-30
665.5 K
Dimensional Fund Advisors, Inc.2024-09-30
638 K
Lpl Financial Corp2024-06-30
591.2 K
Baillie Gifford & Co Limited.2024-09-30
567.4 K
Davidson Kempner Capital Management Lp2024-06-30
550 K
General Equity Holdings Lp2024-09-30
533.5 K
Renaissance Technologies Corp2024-09-30
410.9 K
Pb Investment Partners, L.p.2024-09-30
397.1 K
Charles Schwab Investment Management Inc2024-09-30
390.3 K
Morgan Stanley - Brokerage Accounts2024-06-30
4.3 M
Blackrock Inc2024-06-30
3.2 M
View Cardlytics Diagnostics

Cardlytics Historical Income Statement

At this time, Cardlytics' Selling And Marketing Expenses is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Interest Income is likely to drop slightly above 3.4 M in 2024. View More Fundamentals

Cardlytics Stock Against Markets

Cardlytics Corporate Management

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.